Academic Unit of Inflammation and Tumour Targeting

Our research focuses on:

  • The role of macrophages in tumour progression, anti-cancer gene therapy and response of tumours to conventional therapies.
  • Development of anti-vascular and angiogenic agents.
  • Mathematical modelling of tumour inflammation and angiogenesis.

We gratefully acknowledge the financial support of:

  • The Medical Research Council
  • Cancer Research UK
  • Yorkshire Cancer Research
  • The Breast Cancer Campaign
  • The Prostate Cancer Charity
  • Various companies including AstraZeneca, MedImmune and Syntaxin.